90
Participants
Start Date
December 22, 2023
Primary Completion Date
May 31, 2026
Study Completion Date
July 31, 2027
Lutetium Lu 177 JH020002 Injection
Patients will receive Lutetium Lu 177 JH020002 Injection every 6 weeks for a maximum of 6 doses. Doses range between 1.85 and 8.88 GBq (50-240 mCi)
RECRUITING
Fudan University Shanghai Cancer Center, Shanghai
RECRUITING
Anhui Provincial Hospital, Hefei
RECRUITING
Peking University First Hospital, Beijing
RECRUITING
The First Affiliated Hospital of Fujian Medical University, Fuzhou
RECRUITING
Sun Yat-Sen University Cancer Center, Guangzhou
NOT_YET_RECRUITING
Henan Cancer Hospital, Zhengzhou
RECRUITING
Huazhong University of Science and Technology Tongji Medical College Affiliated Union Hospital, Wuhan
RECRUITING
The First Affiliated Hospital of Soochow University, Suzhou
NOT_YET_RECRUITING
Affiliated Hospital of Jiangsu University, Wuxi
RECRUITING
Shandong Cancer Hospital, Jinan
RECRUITING
West China Hospital of Sichuan University, Chengdu
RECRUITING
Tianjin Cancer Hospital Airport Hospital, Tianjin
RECRUITING
Zhejiang Provincial People's Hospital, Hangzhou
Lead Sponsor
Bivision Pharmaceuticals, Inc.
INDUSTRY